Piramal Pharma Limited had a revenue of 27.54B in the quarter ending Mar 31, 2025, with 24.95%. This bring the company's revenue in the last twelve months to 91.51B, Decreased 2.25%. In the fiscal year ending Mar 31, 2025, Piramal Pharma Limited had annual revenue of 91.51B with 11.99% growth.